go to home page | go to navigation | go to page content | go to contact | go to sitemap
Home > Library > EU: Virtual Physiological Human Projects portfolio 2011 > EU: Virtual Physiological Human Projects portfolio 2011

practice EU: Virtual Physiological Human Projects portfolio 2011

EU: Virtual Physiological Human Projects portfolio 2011

425 Visits |
starstarstarempty starempty starIn order to vote, you need to be logged in!
Published date
30 January 2012
Country
Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, EU Institutions, Africa, Asia, North America, Oceania
Domain
eHealth
Languages
English
Author
Virtual Physiological Human Projects
Publisher
European Commission, Directorate General Information Society and Media
License of the document
Other
Submitted By
ePractice Editorial Team (EUROPEAN DYNAMICS SA) | Belgium
Complete title:
Virtual Physiological Human Projects portfolio 2011

Description (short summary):                   
This resource book provides an overview of the set of Virtual Physiological Human (VPH) research projects managed by the information and communication technology (ICT) for Health unit of the Information Society and Media General Directorate, which are funded under the 6th and 7th (FP6-FP7) framework Programme for Research and Development.

At the core of the VPH lies the idea of translating all functions of the human body into a coherent set of multi-scale computer models. The scales of modelling span spatially from the whole body down to the cells and the proteins they synthesise, and temporally from years to microseconds. The VPH framework will provide ICT tools for developing patient-specific computer based models and simulations using specific patient data allowing for personalised and predictive healthcare.

These multi-scale models will be used to develop an integrative approach to predicting the risk in developing a disease and to improving the diagnosis and treatments of these diseases. During drug development, such organs models could be used to assess the drug effect on a specific population.

Related ePractice News Article:
EU: Institute to promote the Virtual Physisological Human is now fully operational

Multimedia Content Select a Tab

There isn't any SlideShare for this library
There isn't any image for this library
There isn't any Video for this library
In order to send a message you need to be registered at least one month and have earned more than 150 kudos.
Robots should not follow this link
eGovernment